Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.130
-0.020 (-1.74%)
Jun 18, 2026, 2:04 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.41 billion as of June 17, 2026. Its market cap has decreased by -36.46% in one year.
Market Cap
2.41B
Enterprise Value
2.69B
Revenue
1.92B
Ranking
n/a
PE Ratio
11.48
Stock Price
1.13
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.41B, a decrease of -63.62%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.41B | -36.51% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Boan Biotechnology | 3.04B |
| Jiangsu Recbio Technology | 2.97B |
| PegBio | 2.76B |
| BioDlink International Company | 2.74B |
| TYK Medicines | 2.65B |
| Beijing Luzhu Biotechnology | 2.44B |
| Antengene Corporation | 2.40B |
| AIM Vaccine | 2.39B |